SGX-523 2 mg | 99.60%
TargetMol
SGX-523 is a selective Met inhibitor (IC50: 4 nM), no inhibitory to Abl, BRAFV599E, p38α, and c-Raf.
More Information Supplier PageSGX-523
Search Results
SGX-523 10 mg | 99.60%
TargetMol
SGX-523 is a selective Met inhibitor (IC50: 4 nM), no inhibitory to Abl, BRAFV599E, p38α, and c-Raf.
More Information Supplier PageSGX-523
SGX-523 100 mg | 99.60%
TargetMol
SGX-523 is a selective Met inhibitor (IC50: 4 nM), no inhibitory to Abl, BRAFV599E, p38α, and c-Raf.
More Information Supplier PageSGX-523
ITD-1 5 mg | 99.89%
TargetMol
ITD-1
ITD-1 50 mg | 99.89%
TargetMol
ITD-1
ITD-1 10 mg | 99.89%
TargetMol
ITD-1
Tezacaftor 5 mg | Purity Not Available
TargetMol
Tezacaftor (VX661) is a small molecule that can be used as a corrector of the cystic fibrosis transmembrane conductance regulator (CFTR) gene function.
More Information Supplier PageTezacaftor
SGX-523 50 mg | 99.60%
TargetMol
SGX-523 is a selective Met inhibitor (IC50: 4 nM), no inhibitory to Abl, BRAFV599E, p38α, and c-Raf.
More Information Supplier PageSGX-523
SGX-523 5 mg | 99.60%
TargetMol
SGX-523 is a selective Met inhibitor (IC50: 4 nM), no inhibitory to Abl, BRAFV599E, p38α, and c-Raf.
More Information Supplier PageSGX-523
PIK-294 10 mg | 99.00%
TargetMol
PIK-294
